Skip to main content
First-in-class TYK inhibitor shows durable effect for psoriasis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
First-in-class TYK inhibitor shows durable effect for psoriasis
User login
Username
Password
Reset your password
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Internal Medicine
0
0.7
Rheumatology
0
0.9
Concept
Lead
score
Nucleoside Reverse Transcriptase Inhibitors
0
1
Biologic Therapy
0
0.86
Psoriasis
0
0.99
Psoriatic Arthritis
0
0.98
Clinical Research
0
0.37
Plaque Psoriasis
0
0.97
Scalp
0
0.15
Adverse Effects
0
0.07
Arthritis
0
0.07
Brachial
0
0.07
Cyclosporine
0
0.07
Cytokines
0
0.07
Europe
0
0.07
Interleukin
0
0.07
Monoclonal Antibody
0
0.07
New York
0
0.07
Pathogenesis
0
0.07
Tyrosine Kinase
0
0.96
Viral Infection
0
0.07
Herpes Zoster
0
0.06
Patient Safety
0
0.06